About

Publications While At Healthpartners

selected publications

Journal Article

Islet autoimmunity is highly prevalent and associated with diminished β-cell function in patients with type 2 diabetes in the Grade Study. 

Diabetes. 2022

Rationale and design for a GRADE substudy of continuous glucose monitoring. 

Diabetes Technology & Therapeutics. 2019

Factors associated with failure to achieve a glycated haemoglobin target of <8.0% in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. 

Diabetes, Obesity & Metabolism. 2016

Effects of TZD use and discontinuation on fracture rates in ACCORD Bone Study. 

Journal of Clinical Endocrinology and Metabolism. 2015

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. 

Diabetes care. 2014

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 

Lancet (London, England). 2010

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 

Lancet (London, England). 2010

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. 

Diabetes care. 2010

Abstract

Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]. 

Diabetes. 2012

Contact

full name

R. M. Cohen

Quick Info

 

Collaboration

Co-author network

Map of science